762648

    526783

    DRAGARWQ

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Dr Agarwal S Eye Hosp L Share Price Today

    DR. AGARWAL'S EYE HOSP L made its stock market debut on 20 April 2026 and is currently trading at ₹5000, up by ₹0.5 from the previous close. The stock touched an intraday high of ₹5049.50 and a low of ₹4950.50 during the latest trading session.

    Dr Agarwal S Eye Hosp L performance

    Today’s low Today’s high
    ₹ 4950.50 ₹ 5049.50
    ₹ 4995.00
    52 week low 52 week high
    ₹ 4600.00 ₹ 6059.70
    ₹ 4995.00
    Open Price ₹ 5001.50
    Prev. Close ₹ 4999.50
    Volume (Shares) 328.00
    Total traded value ₹ 16.38
    Upper Circuit ₹ 5999.00
    Lower Circuit ₹ 4000.00
    info

    Investment Returns

    Over 1 Month 0.19% Over 3 Months 4.42% Over 6 Months 0.00% Over 1 Year 0.00%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Dr Agarwal S Eye Hosp L fundamentals


    • Market cap (Cr) 2,414.00
    • P/E Ratio (TTM) 34.51
    • Beta 0.07
    • Book Value / share 716.56
    • Return on equity 29.80%
    • EPS (TTM) 145.05
    • Dividend yield 0.08%
    • Net profit/quarter (Cr) 16.24
    info icon alternate text
    • Market cap (Cr) 2,416.40
    • P/E Ratio (TTM) 34.51
    • Beta 0.33
    • Book Value / share 716.56
    • Return on equity 29.80%
    • EPS (TTM) 145.05
    • Dividend yield 0.08%
    • Net profit/quarter (Cr) 16.24
    info icon alternate text

    Dr Agarwal S Eye Hosp L Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 120.01
    Operating Expense 100.33
    Net Profit 16.24
    Net Profit Margin (%) 13.53
    Earnings Per Share (EPS) 33.60
    EBITDA 35.30
    Effective Tax Rate (%) 23.57
    Particulars DEC 2025 (Values in Cr)
    Revenue 116.22
    Operating Expense 95.54
    Net Profit 17.28
    Net Profit Margin (%) 14.86
    Earnings Per Share (EPS) 35.76
    EBITDA 37.14
    Effective Tax Rate (%) 26.31
    Particulars SEP 2025 (Values in Cr)
    Revenue 117.72
    Operating Expense 92.68
    Net Profit 19.32
    Net Profit Margin (%) 16.41
    Earnings Per Share (EPS) 41.04
    EBITDA 40.76
    Effective Tax Rate (%) 24.88
    Particulars JUN 2025 (Values in Cr)
    Revenue 116.92
    Operating Expense 94.53
    Net Profit 17.26
    Net Profit Margin (%) 14.76
    Earnings Per Share (EPS) 36.72
    EBITDA 37.93
    Effective Tax Rate (%) 25.57
    Particulars MAR 2025 (Values in Cr)
    Revenue 99.83
    Operating Expense 81.33
    Net Profit 15.99
    Net Profit Margin (%) 16.01
    Earnings Per Share (EPS) 34.02
    EBITDA 31.69
    Effective Tax Rate (%) 14.03
    Particulars MAR 2026 (Values in Cr)
    Revenue 470.87
    Operating Expense 383.08
    Net Profit 70.10
    Net Profit Margin (%) 14.88
    Earnings Per Share (EPS) 147.02
    EBITDA 151.13
    Effective Tax Rate (%) 25.11
    Particulars MAR 2025 (Values in Cr)
    Revenue 397.15
    Operating Expense 331.54
    Net Profit 54.65
    Net Profit Margin (%) 13.76
    Earnings Per Share (EPS) 116.28
    EBITDA 123.59
    Effective Tax Rate (%) 22.70
    Particulars MAR 2024 (Values in Cr)
    Revenue 319.30
    Operating Expense 262.02
    Net Profit 46.36
    Net Profit Margin (%) 14.51
    Earnings Per Share (EPS) 98.64
    EBITDA 96.03
    Effective Tax Rate (%) 25.52
    Particulars MAR 2023 (Values in Cr)
    Revenue 268.10
    Operating Expense 220.25
    Net Profit 36.92
    Net Profit Margin (%) 13.77
    Earnings Per Share (EPS) 78.55
    EBITDA 76.44
    Effective Tax Rate (%) 25.26
    Particulars MAR 2022 (Values in Cr)
    Revenue 201.21
    Operating Expense 170.16
    Net Profit 24.10
    Net Profit Margin (%) 11.97
    Earnings Per Share (EPS) 51.29
    EBITDA 58.93
    Effective Tax Rate (%) 25.41
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 445.98
    ROE % 29.80
    ROCE % 17.30
    Total Debt to Total Equity 1.64
    EBITDA Margin 31.47
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 334.36
    ROE % 34.28
    ROCE % 17.89
    Total Debt to Total Equity 1.85
    EBITDA Margin 30.43
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 241.15
    ROE % 38.56
    ROCE % 18.22
    Total Debt to Total Equity 2.22
    EBITDA Margin 28.95
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 166.32
    ROE % 36.29
    ROCE % 19.63
    Total Debt to Total Equity 1.96
    EBITDA Margin 29.77
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 116.30
    ROE % -2.60
    ROCE % 10.36
    Total Debt to Total Equity 1.15
    EBITDA Margin 22.74
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 12.17
    Total Assets 613.32
    Total Liabilities 613.32
    Total Equity 209.61
    Share Outstanding 0
    Price to Book Ratio 9.09
    Return on Assets (%) 8.91
    Return on Capital (%) 17.86
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 33.74
    Total Assets 495.76
    Total Liabilities 495.76
    Total Equity 157.15
    Share Outstanding 0
    Price to Book Ratio 9.28
    Return on Assets (%) 9.35
    Return on Capital (%) 22.24
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 28.10
    Total Assets 389.94
    Total Liabilities 389.94
    Total Equity 113.34
    Share Outstanding 0
    Price to Book Ratio 3.80
    Return on Assets (%) 9.46
    Return on Capital (%) 23.49
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 28.80
    Total Assets 314.01
    Total Liabilities 314.01
    Total Equity 78.17
    Share Outstanding 0
    Price to Book Ratio 4.39
    Return on Assets (%) 7.67
    Return on Capital (%) 21.89
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 22.19
    Total Assets 155.23
    Total Liabilities 155.23
    Total Equity 54.66
    Share Outstanding 0
    Price to Book Ratio 2.69
    Return on Assets (%) -0.92
    Return on Capital (%) -1.89
    Particulars MAR 2025 (Values in Cr)
    Net Income 70.70
    Cash from Operations 114.61
    Cash from Investing -132.78
    Cash from Financing 16.58
    Net change in Cash -21.72
    Free Cash Flow 217.47
    Particulars MAR 2024 (Values in Cr)
    Net Income 62.25
    Cash from Operations 103.38
    Cash from Investing -70.04
    Cash from Financing -14.23
    Net change in Cash 5.50
    Free Cash Flow 174.70
    Particulars MAR 2023 (Values in Cr)
    Net Income 49.40
    Cash from Operations 81.14
    Cash from Investing -70.61
    Cash from Financing 0.26
    Net change in Cash -0.73
    Free Cash Flow 151.48
    Particulars MAR 2022 (Values in Cr)
    Net Income 24.10
    Cash from Operations 65.61
    Cash from Investing -46.28
    Cash from Financing -3.81
    Net change in Cash 6.59
    Free Cash Flow 112.34
    Particulars MAR 2021 (Values in Cr)
    Net Income -1.43
    Cash from Operations 37.19
    Cash from Investing -10.96
    Cash from Financing -7.59
    Net change in Cash 15.30
    Free Cash Flow 48.38
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8892.30 65.36 13.49 127857.63 6680.00 8927.00
    FORTIS MALAR HOSPITALS LIMITED 51.75 23.42 2.82 96.99 40.75 76.00
    SHREE PACETRONIX LTD. 130.35 15.55 2.74 48.88 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.07 0.00 2.77 23.26 1.83 5.26
    VIMTA LABS LTD. 478.55 35.16 6.23 2137.65 377.30 902.85
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8892.30 85.17 12.83 127857.63 6680.00 8927.00
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 39.40 0.00 -9.58 29.43 30.30 57.48
    KOVAI MEDICAL CENTER & HO 6013.10 26.91 4.98 6578.33 5010.00 6725.00

    Dr Agarwal S Eye Hosp L shareholding pattern

    Holding
    23.0%
    72.66%
    2.2%
    2.12%
    29.26%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Dr Agarwal S Eye Hosp L Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    4995.00 -0.09 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 5032.30
    • 26 Days 5028.20
    • 10 Days 5033.70
    • 50 Days 5029.40
    • 12 Days 5032.80
    • 100 Days 5029.20
    • 20 Days 5030.10
    • 200 Days 5029.20
    5040.83 PIVOT
    First Support 4938.67 First Resistance 5101.67 Second Support 4877.83 Second Resistance 5203.83 Third Support 4775.67 Third Resistance 5264.67
    RSI 48.61 ADX 5.49 MACD 4.62 Williams % R -46.25 Commodity Channel Index (CCI) 54.75
    Date 2026-07-06 Week 598.00 Same Day 781.00 Month 495.00
    1 Year 0.08 3 Year 0.07
    Over 1 Month
    0.19% down
    Over 1 Year
    0.00% down
    Over 3 Months
    4.42% down
    Over 3 Years
    0.00% down
    Over 6 Months
    0.00% down
    Over 5 Years
    0.00% down

    Dr Agarwal S Eye Hosp L Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    07 Nov 2025 3.0 Interim 07 Nov 2025 Equity shares
    18 Sep 2025 3.5 Final 18 Sep 2025 Equity shares
    08 Nov 2024 2.5 Interim 08 Nov 2024 Equity shares
    19 Aug 2024 2.5 Final 20 Aug 2024 Equity shares
    31 Oct 2023 2.5 Interim 31 Oct 2023 Equity shares
    14 Sep 2023 3.0 Final 15 Sep 2023 Equity shares
    06 Sep 2022 3.0 Final 08 Sep 2022 Equity shares
    16 Sep 2019 1.5 Final 18 Sep 2019 Equity shares
    21 Aug 2018 1.2 Final 24 Aug 2018 Equity shares
    14 Aug 2017 1.5 Final 17 Aug 2017 Equity shares
    12 Aug 2016 0.8 Final 17 Aug 2016 Equity shares
    01 Sep 2015 1.2 Final 03 Sep 2015 Equity shares
    28 Aug 2014 1.2 Final 02 Sep 2014 Equity shares
    02 Aug 2013 1.2 Final 06 Aug 2013 Equity shares
    11 Aug 2011 1.2 Final 16 Aug 2011 Equity shares
    13 Aug 2010 0.8 Final 17 Aug 2010 Equity shares
    13 Sep 2007 1.5 Final 15 Sep 2007 Equity shares
    12 Sep 2005 0.0 Final 14 Sep 2005 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    07 Nov 2025 3.0 Interim 07 Nov 2025 Equity shares
    18 Sep 2025 3.5 Final 18 Sep 2025 Equity shares
    08 Nov 2024 2.5 Interim 08 Nov 2024 Equity shares
    19 Aug 2024 2.5 Final 20 Aug 2024 Equity shares
    31 Oct 2023 2.5 Interim 31 Oct 2023 Equity shares
    14 Sep 2023 3.0 Final 15 Sep 2023 Equity shares
    06 Sep 2022 3.0 Final 08 Sep 2022 Equity shares
    16 Sep 2019 1.5 Final 18 Sep 2019 Equity shares
    21 Aug 2018 1.2 Final 24 Aug 2018 Equity shares
    14 Aug 2017 1.5 Final 17 Aug 2017 Equity shares
    12 Aug 2016 0.8 Final 17 Aug 2016 Equity shares
    01 Sep 2015 1.2 Final 03 Sep 2015 Equity shares
    28 Aug 2014 1.2 Final 02 Sep 2014 Equity shares
    02 Aug 2013 1.2 Final 06 Aug 2013 Equity shares
    11 Aug 2011 1.2 Final 16 Aug 2011 Equity shares
    13 Aug 2010 0.8 Final 17 Aug 2010 Equity shares
    13 Sep 2007 1.5 Final 15 Sep 2007 Equity shares
    12 Sep 2005 0.0 Final 14 Sep 2005 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Dr Agarwals Eye Hospital Ltd?

    Answer Field

    Dr Agarwals Eye Hospital Ltd share price is for NSE ₹ 5,000.00 & for BSE ₹ 5,004.05 as on Jul 07 2026 03:29 PM.

    What is the Market Cap of Dr Agarwals Eye Hospital Ltd Share?

    Answer Field

    The market cap of Dr Agarwals Eye Hospital Ltd for NSE ₹ 2,414.00 & for BSE ₹ 0.00 as on Jul 07 2026 03:29 PM.

    What is the 52 Week High and Low of Dr Agarwals Eye Hospital Ltd?

    Answer Field

    The 52 Week High and Low of Dr Agarwals Eye Hospital Ltd for NSE is ₹ 6,059.70 and ₹ 4,600.00 and for BSE is ₹ 6,392.00 and ₹ 4,231.00.

    What is 1 year return for Dr Agarwals Eye Hospital Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.00%.

    What is the P/E Ratio of Dr Agarwals Eye Hospital Ltd Share?

    Answer Field

    As on Jul 07 2026 03:29 PM the price-to-earnings (PE) ratio for Dr Agarwals Eye Hospital Ltd share is 34.51.

    What is the PB ratio of Dr Agarwals Eye Hospital Ltd Share?

    Answer Field

    As on Jul 07 2026 03:29 PM, the price-to-book (PB) ratio for Dr Agarwals Eye Hospital Ltd share is 716.56.

    How to Buy Dr Agarwals Eye Hospital Ltd Share?

    Answer Field

    You can trade in Dr Agarwals Eye Hospital Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Dr Agarwals Eye Hospital Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Dr Agarwals Eye Hospital Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Dr Agarwals Eye Hospital Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |